Fundus Autofluorescence and Spectral Domain OCT in Central Serous Chorioretinopathy by Roisman, Luiz et al.
Hindawi Publishing Corporation
Journal of Ophthalmology
Volume 2011, Article ID 706849, 4 pages
doi:10.1155/2011/706849
Research Article
Fundus Autofluorescence and Spectral Domain OCT in Central
Serous Chorioretinopathy
Luiz Roisman, Daniel Lavinsky, Fernanda Magalhaes, Fabio Bom Aggio, Nilva Moraes,
Jose A. Cardillo, and Michel E. Farah
Department of Ophthalmology, Federal University of Sa˜o Paulo, Paulista School of Medicine, 04025-011 Sa˜o Paulo, SP, Brazil
Correspondence should be addressed to Luiz Roisman, luizroi@yahoo.com.br
Received 28 November 2010; Accepted 20 June 2011
Academic Editor: Fernando M. Penha
Copyright © 2011 Luiz Roisman et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. To describe the standard autofluorescence (FAF), the near infrared autofluorescence (NIA) and optical coherence
tomography (OCT) patterns in central serous chorioretinopathy, correlating them with fluorescein angiography. Methods. Cross-
sectional observational study, in which patients with at least sevenmonths of CSC underwent ophthalmologic examination, fundus
photography, FAF, NIA, fluorescein angiography (FA), and spectral-domain OCT. Results. Seventeen eyes of thirteen patients were
included. The presentation features were a mottled hyperFAF in the detached area and areas with pigment mottling. NIA images
showed areas of hyperNIA similar to FAF and localized areas of hypoNIA, which correlated with the points of leakage in the FA.
OCT showed pigment epithelium detachment at the location of these hypoNIA spots. Discussion. FAF showed increased presence
of fluorophores in the area of retinal detachment, which is believed to appear secondary to lipofuscin accumulation in the RPE or
the presence of debris in the subretinal fluid. NIA has been related to the choroidal melanin content and there were areas of both
increased and decreased NIA, which could be explained by damage ahead the retina, basically RPE and choroid. These findings,
along with the PEDs found in the areas of hypoNIA, support the notion of a primary choroidal disease in CSC.
1. Introduction
Central serous chorioretinopathy (CSC) is an idiopathic syn-
drome of young to middle-aged adults, characterized by se-
rous detachment of the neurosensory retina with focal and
multifocal areas of leakage at the level of the retinal pigment
epithelium (RPE), predominantly aﬀecting the macular
area [1]. Patients often complain of blurred central vision,
micropsia, and metamorphopsia [2]. This idiopathic syn-
drome has been associated with systemic corticosteroid ther-
apy [3] and emotional distress [4]. In most cases, CSC re-
solves spontaneously within six months, with good visual
prognosis [5]. Prolonged and recurrent macular detachment
in some cases, however, may cause degenerative changes in
the subfoveal RPE and neurosensory retina with poor visual
outcome [6].
The understanding of the physiopathology of CSC re-
mains limited due to the lack of significant histopathologic
studies. Investigational and diagnostic tools such as fluo-
rescein and indocyanine green angiography have provided
some insight into the mechanism of this disease [7]. Optical
coherence tomography (OCT) has provided additional data
about central macular detachments [8], development of reti-
nal atrophy, and the correlation with visual acuity in resolved
central serous chorioretinopathy [9]. Fundus autofluores-
cence (FAF) photography (488 nm) provides functional
images of the fundus by employing the stimulated emission
of light from endogenous fluorophores, the most significant
being lipofuscin. In the case of RPE cells, the buildup of lipo-
fuscin is related in large part to the phagocytosis of damaged
photoreceptor outer segments and alteredmolecules retained
within lysosomes, which eventually become lipofuscin [10–
12]. Moreover, near infrared fundus autofluorescence (NIA)
imaging (787 nm) is able to study the RPE, the choriocapil-
laris, and choroid, by determiningmelanin fluorescence [13].
The purpose of this study was to describe NIA and SD-
OCT findings in CSC, correlating them with fluorescein
angiography (FA). To our knowledge, this is the first study
that investigates the correlation between the clinical findings
and diﬀerent imaging modalities, specially with NIA.
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Table 1
FAF (%) NIA(%)
hypoFAF mixedFAF hyperFAF hypoNIA mixedNIA hyperNIA
Detached area (N = 10) 10 20 70 30 20 50
Leakage spot (N = 13) 23.1 × 76.9 92.3 × 7.7
Window defect area (N = 8) 12.5 12.5 75 62.5 32.5 0
Overall image (N = 17) 17.6 11.8 70.6 58.8 17.6 23.5
PED (N = 22) 63.6 × 36.4
2. Materials and Methods
This is a retrospective, cross-sectional study were patients
with CSCwere included from September 2008 toMay 2009 at
the Federal University of Sao Paulo. This study was conduct-
ed in accordance with the Declaration of Helsinki and was
approved by the ethics committee of the Federal University
of Sao Paulo. All patients had experienced symptoms for at
least 7 months and none of them had previous treatment.
Each patient underwent ophthalmologic examination,
color fundus photography, FAF and NIA imaging, fluores-
cein angiography (FA), and HRA Spectralis spectral-domain
OCT (SD-OCT) (Heidelberg Engineering, Heidelberg, Ger-
many). The OCT protocol used was volume in the SD-OCT.
The volume size was individualized for each patient. FAF,
NIA, and FA imaging were performed with the Heidelberg
Retina Angiograph 2 system (HRA2, Heidelberg, Germany).
FAF and NIA images were recorded at 488 nm, using a
barrier filter for detection of emitted light above 500 nm, and
787 nm, respectively. At least 5 single AF images of 512× 512
pixels were acquired with each method. Several images were
aligned and a mean image was calculated after detection and
correction of eye movements using image analysis software.
Abnormal AF was defined as either increased or de-
creased fundus AF in comparison with background fundus
AF [13], and classified as either hyperautofluorescence,
hypo-autofluorescence, or mixed autofluorescence (no clear
predominance).
3. Results
We included 17 eyes of 13 patients, eight males, and five
females, presenting CSC with a mean time of complaint of
12.7 months, ranging from 7 months to 2 years, with age
ranging from 26 to 53 years (mean age of 39.3 years). Two
individuals had history of using steroids, but had stopped
the use for at least 6 months. Fifteen patients had a relapsing
desease and two were in the first episode.
Fluorescein angiography showed in 8 (47%) eyes focal
leakage, in 1 (5.9%)multifocal leakage, in 4 (23.5%)multiple
window defect with diﬀuse leakage, and in 4 (23.5%) no
leakage.
Ten eyes exhibited serous retinal detachment. Of those,
1 presented with multifocal leakage, 7 with focal leakage,
and 2 with RPE changes and multiple windows defects. The
detached area revealed hyperFAF in 7 (70%), mixedFAF in 2
(20%), and hypoFAF in 1 (10%). HypoNIA could be seen in
5 (50%), mixedNIA in 2 (20%), and hyperNIA in 3 (30%).
The areas of window defects seen at FA in 8 eyes showed
hyperFAF in 6 (75%), mixedFAF and hypoFAF in 1 eye
each (12.5%). Concerning NIA of the window defects areas,
we could find 5 eyes indicating hypoNIA (62.5%) and 3
mixedNIA (37.5%).
The overall FAF images revealed hyperFAF in 12 (70.6%)
eyes, hypoFAF in 3 (17.6%) eyes, andmixed FAF in 2 (11.8%)
eyes. The overall NIA images presented hyperNIA in 4
(23.5%) eyes, hypoNIA in 10 (58.8%), and mixed NIA in 3
(17.6%) eyes. Twelve of thirteen eyes with leakage showed a
hypoNIA exactly at the leaking spot. A hypoFAF was found
in 3 eyes in the leakage site. The location of autofluorescence
alterations were perimacular, following the leakage and the
RPE damage sites (Table 1).
The Spectralis OCT images revealed 10 (58.8%) foveal
neurosensory retinal detachment. The mean foveal retinal
thickness was 332.6 µm, ranging from 220 to 533 µm. Pig-
ment epithelium detachment (PED) in foveal and/or ex-
trafoveal spots was identified in 11 of the 13 patients, in
a total of 22 PEDs in 15 of 17 eyes. Twelve (54.5%) were
foveals and ten extra foveals (45.4%). We could observe in
5 eyes a substantial RPE irregularity, characterized by RPE
undulations, 2 of them without PED.
A hyperNIA spot in the NIA images could be seen in 8
(36.4%) of the PEDs and in 14 (63.6%) corresponding to
hypoNIA sites. In 7 (31.8% of all PEDs) of the 14 PEDs
that corresponded to hypoNIA images, we could identify
a hyperNIA “ring.” In 14 (63.6%) of the PEDs, we found
that the PED corresponded exactly with the leakage spot
detected in FA, and 7 (31.8%) PEDs corresponded to window
defect areas in FA, while 1 (4.5%) PED did not correlate with
FA alterations. The 14 PEDs that correlated with the point
of leakage showed a hyperNIA point in 5 (35.7%) PEDs,
hypoNIA with hyperNIA “ring” in 4 (28.6%), and hypoNIA
without ring in 5 (35.7%) of the leakage PEDs (Figures 1, 2
and 3).
4. Discussion
NIA is not a common used modality of the HRA2, but its
importance when studying the choroid and outer retina had
been described before [13]. Recently, Kellner et al. suggests
that NIA is a reliable method for RPE evaluation in AMD
[14]. It can be very helpful for conditions such as CSC, in
which the choroid appears to be primarily involved. In the
present study, it was shown that the mostly hypofluorescent
spots on NIA images corresponded to pigment epithelium
detachments on OCT and to leakage points on fluorescein
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Figure 1: Patient with 12 months of history of CSC in the right eye.
(a) Two dots spots of leakage in the angiography; (b) standard FAF,
presenting with diﬀuse hyperFAF; (c) NIA, showing suprafoveal
hypofluorescent point surrounded by a ring of hyperAF, corre-
sponding exactly with the PEDs in (d); (d) SD-OCT exhibiting the
PED and neurosensorial retinal detachment.
(a) (b) (c)
(d)
Figure 2: Patient with 9 months of history of CSC in the right eye.
(a) Standard FAF, showing mottled hyperFAF spots; (b) NIA, pre-
senting macular and supratemporal to the optic disk hypofluores-
cent points—the macular spot surrounded by a ring of hyperAF,
corresponding exactly with the PED in (d); (c) spots of leakage in
the angiography; (d) SD-OCT exhibiting the PED.
angiography. The hypoNIRAF spot could identify the leakage
points in 12 (70.6%) of the eyes and the ring of hyperNIA
around these hypofluorescent spots found in 31.8% of all
PEDs could represent “pooling” of RPE cells because of the
PEDs or local RPE folding, but further studies are needed to
confirm this hypothesis.
The FAF images showed hyperFAF in the great majority
of the cases, probably due to accumulation of lipofuscin and
other fluorophores, as described by Spaide and Klancnik [7].
We found a much weaker correlation between a hypoFAF
spot at the leakage site, as reported by Framme et al. [15],
(a) (b) (c)
(d)
(e)
Figure 3: Patient with 18 months of history of CSC in the right
eye. (a) dots spots of leakage in the angiography; (b) standard
FAF, showing diﬀuse superior hyperFAF; (c) NIA, showing three
hypofluorescent spots around the macula, some of them corre-
sponding exactly with the PEDs in (d) and (e); (d) and (e) SD-OCT
exhibiting the PEDs and neurosensorial retinal detachment.
detected only in 3 eyes, comparing to 12 eyes with a hypoNIA
spot in the same situation.
Ayata et al. [16] had similar findings in acute CSC, also
presenting hypoNIA corresponding to the area of the serous
retinal detachment and to the leakage point. Interestingly,
he also found hypoNIA spots that were not leaking on
angiogram, hypothesizing that the pathological site of the
chorioretinal disturbance could be more extensive than
expected. We had the opportunity to correlate the NIA
images to OCT, and the hipoNIA spots, corresponding or not
to leaking points, presented a PED or RPE focal irregularity,
sustaining a choroidal etiology for CSC.
Almost 60% of NIA examinations showed diﬀuse
hypoNIA, although almost 25% displayed hyperNIA. These
results may represent diﬀerent stages of the disease. We did
not observe the minute defect described by Fujimoto et al.
[17] in any of the cases, although we confirmed the relation
between the PED and the leakage site, seen in more than 63%
of PEDs. The presence of leakage in the PEDs spots could
help explain the CSC recurrence, the persistence of retinal
detachment and symptoms in some cases, as the PEDs are
active, in terms of leakage and lower RPE absorption.
One of the most interesting findings of this study, was
the correlation of the PED in the SD-OCT with the hypoNIA
spot and the point of leakage in the fluorescein angiography
(FA). Almost 60% of PEDs corresponded to leaking sites
that corresponded to hypoNIA areas, and twelve of thirteen
eyes that showed leakage had a hypoNIA spot exactly at the
leaking spot. Although FA is still an important exam for
the management of CSC, these findings may be useful in
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guiding the treatment, since OCT and NIA may provide the
location of leakage points bymeans of a noninvasive, dye-free
examination, providing safety and precision for the patient
and the doctor, matching with the treatment safety pursuit,
as we can expect from the subthreshold diode micropulse
photocoagulation [18]. This is a retrospective, not controlled
or randomized study, evaluating chronic CSC eyes. A larger
sampled study, including acute cases, are warranted to
confirm these preliminary results.
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